Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer’s Disease
Alzheimer's disease (AD) is a complex neurodegenerative disease characterized by cognitive dysfunction. Kai-Xin-San (KXS) is a traditional Chinese medicine (TCM) formula that has been used to treat AD patients for over a thousand years in China. However, the therapeutic mechanisms of KXS for tr...
Main Authors: | Yunxia Luo, Dongli Li, Yanfang Liao, Chuipu Cai, Qihui Wu, Hanzhong Ke, Xinning Liu, Huilin Li, Honghai Hong, Yumin Xu, Qi Wang, Jiansong Fang, Shuhuan Fang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.00381/full |
Similar Items
-
Corrigendum: Systems pharmacology approach to investigate the mechanism of Kai-Xin-San in Alzheimer’s disease
by: Yunxia Luo, et al.
Published: (2023-10-01) -
Kai Xin San ameliorates scopolamine-induced cognitive dysfunction
by: Yu-Min Xu, et al.
Published: (2019-01-01) -
Research on the quality markers of antioxidant activity of Kai-Xin-San based on the spectrum–effect relationship
by: Xiaoxiao Shan, et al.
Published: (2023-12-01) -
MiR-1281 is involved in depression disorder and the antidepressant effects of Kai-Xin-San by targeting ADCY1 and DVL1
by: Chao Chen, et al.
Published: (2023-03-01) -
A Modified Chinese Herbal Decoction (Kai-Xin-San) Promotes NGF-Induced Neuronal Differentiation in PC12 Cells via Up-Regulating Trk A Signaling
by: Lu Yan, et al.
Published: (2017-12-01)